FDA Drug Shortage Alerts: Track New, Updated and Resolved Entries
FDA already emails drug shortage updates. Here is what its database and drug pages show, and a rule that catches a real availability change without the noise.
By AyeWatch Team4 min read
Short answer: FDA's Drug Shortages database has a Get Email Alerts link, so start there for free email. Add an AyeWatch web page monitor when you want a rule on one drug, such as alerting only when availability or the estimated recovery date changes, with a short summary and a link to the entry.
The FDA Drug Shortages database lists drugs that FDA tracks as currently in shortage, resolved or discontinued. Each drug has its own page with a status, a table of manufacturers and an estimated recovery date when one is known.
What FDA publishes and what it already emails
FDA runs the database at accessdata.fda.gov/scripts/drugshortages/. The main page has four tabs: Current/Resolved Shortages, Discontinuations, Therapeutic Categories, and New and Updated. A drug is marked "Currently in Shortage", "Resolved" or "Discontinuation".
FDA already sends email. The page has a "Get Email Alerts" link, a "Download Current Drug Shortages" file and a historical Excel download. The openFDA Drug Shortages API returns the same data as JSON and lists its update frequency as daily. If you want every change to every drug in your inbox, the email link is enough and you can stop reading.
What one drug page shows
Each drug name opens its own page. The page for heparin sodium injection, as we read it on 19 November 2026, shows a status, a "Date first posted" and a therapeutic category. Below that sits a table for each manufacturer with the columns Presentation, Availability and Estimated Shortage Duration, Related Information and Shortage Reason. Availability reads Available, Unavailable or Limited Availability, and an estimate appears as text like "Estimated recovery: late Q1 2027".
Each manufacturer heading carries a date marked "Revised" or "Reverified". Treat the two differently. A new Reverified date with nothing else changed is the kind of edit most readers want to skip. A changed availability value or a moved recovery estimate is the edit worth an alert.
The rule that catches a real change
Sample rule. "Alert me when the status of Marlowine injection changes, when any presentation moves between Available, Limited Availability and Unavailable, or when the estimated recovery date moves. Ignore changes that only update a Reverified date." Marlowine is a made-up drug name.
Sample alert. The headline reads "Marlowine injection: one manufacturer now lists Limited Availability." The summary says the status is still Currently in Shortage, one 5 mL vial moved from Available to Limited Availability, and the estimated recovery moved from Q1 to Q2 2027. A second manufacturer's entry only has a new Reverified date, so the alert leaves it out. It links to the drug page.
Test the first check before you trust it
The main database page is long. When we read it on 19 November 2026 its text ran past 129,000 characters, because the tabs share one page. AyeWatch reads a page up to a size limit, so a very long page may be read in part. The first check shows what AyeWatch found. If it lists drugs from across the alphabet, the page is readable. If it stops early, monitor the drugs you care about on their own pages instead.
Government sites also treat automated readers differently. FDA's database sent one of our scripted requests to an abuse-detection page and showed another the full list. A site that blocks automated readers may not work, so read the first result before you rely on the monitor.
When AyeWatch is the wrong tool
FDA's list is not a stock report. FDA assigns "Resolved" when at least one manufacturer covers the market, and says some presentations may still be unavailable. A hospital pharmacy still has to ask its wholesaler. A monitor also checks on a schedule, hourly on Pro, so it is not a clinical alert. For patient care or purchasing decisions, use FDA's pages and your supplier.
If you need history or a spreadsheet, use the download files or the API. If FDA's own email already tells you what you need, keep it. Approvals are a different list, covered in FDA approval alerts.
Cost and effort
One drug page is one topic. AyeWatch Pro is $9/mo with 50 topics and hourly checks; Pro+ is $19/mo with 200 topics and ASAP mode. Every plan starts with a 7-day free trial. Fifty topics covers the drugs a small pharmacy worries about most. The dates on the page we read were days apart, so hourly checks are more than enough.
| Need | Best source | Why |
|---|---|---|
| Email on every change | FDA's Get Email Alerts link | Free and official |
| One drug's availability and recovery date | AyeWatch page monitor on that drug's page | A rule can ignore Reverified dates |
| New entries across the whole list | AyeWatch page monitor on the database page, after a test | The page is long, so check the first result |
| Bulk data or history | FDA download files or the openFDA API | Built for export, updated daily |
| News about a shortage | AyeWatch internet monitor on the drug name | Adds coverage and manufacturer statements |
Start a monitor in under a minute
Describe a topic or paste a URL. Cancel before the trial ends and you pay nothing.
Try it free for 7 daysThe bottom line
Turn on FDA's email alerts first, since they cost nothing. Then add one AyeWatch monitor on the single drug page you care about most, with a rule that ignores Reverified dates, and run it for a week to see which alerts you would have missed.
FAQ
Does the FDA send drug shortage alerts?
Yes. The Drug Shortages database page has a Get Email Alerts link. It is free and covers FDA's own updates.
Where is the official FDA drug shortage list?
At accessdata.fda.gov/scripts/drugshortages/. It has tabs for current and resolved shortages, discontinuations, therapeutic categories, and new and updated entries.
Can I get an alert for one drug only?
Yes. Point an AyeWatch web page monitor at that drug's page and write a rule about its status, its availability or its estimated recovery date.
Does a Resolved status mean the drug is back in stock?
Not always. FDA assigns Resolved when at least one manufacturer covers the market, and it says some presentations may still be unavailable.
Is there an API for drug shortages?
Yes. The openFDA Drug Shortages API returns FDA's shortage data as JSON and lists its update frequency as daily.
